Clinical Trial Update: Botulinum Toxin (BOTOX) for Cerebral Palsy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating botulinum toxin (BOTOX) for cerebral palsy-associated muscle spasticity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy
• Muscle Spasticity

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Cerebral Palsy, Muscle Spasticity | Phase 2 | Status: COMPLETED